SutroVax Inc. Funding & Investors
San Carlos, CA
SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines.
sutrovax.comTotal Amount Raised: $2,347,040,000
SutroVax Inc. Funding Rounds
Post Ipo Equity
$862,500,000
Post Ipo Equity
$500,000,000
Post Ipo Equity
$600,000,000
Post Ipo Equity
$100,000,000
Grant
$3,200,000
Grant Investors
CARB-XGrant
$2,700,000
Grant Investors
CARB-XSeries D
$110,000,000
Series D Investors
Henderson Global InvestorsRa Capital ManagementFrazier ManagementAbingworthMedicxiForesite CapitalTpg CapitalRoche Venture FundCTI Life Sciences FundLongitude CapitalPivotal bioVenture Partners Investment AdvisorIPO
Unknown
Grant
$1,640,000
Grant Investors
CARB-XSeries C
$85,000,000
Series C Investors
Tpg CapitalRoche Venture FundMedicxiForesite CapitalAbingworthSeries B
$60,000,000
Series B Investors
Frazier ManagementPivotal bioVenture Partners Investment AdvisorAbingworthLongitude CapitalRoche Venture FundCTI Life Sciences FundSeries A
$22,000,000
Series A Investors
AbingworthLongitude CapitalRoche Venture FundCTI Life Sciences Fund
Funding info provided by Diffbot.